MYMD - Oramed MyMD surge on plans for early-stage oral COVID vaccine data release in Q3

• Oramed Pharmaceuticals' ( NASDAQ: ORMP ) Thursday announcement it will report Q1 data on its oral COVID-19 vaccine this quarter has boosted its shares as well as that of MyMD Pharmaceuticals ( NASDAQ: MYMD ).
• MyMD ( MYMD ) partially owns Oravax Medical, a subsidiary of Oramed ( ORMP ) that is developing the vaccine.
• In early afternoon trading, Oramed ( ORMP ) was up ~25% while MyMD added ~27% .
• Volume in both companies was also high. as of 1245p ET, ~3.2M Oramed ( ORMP ) shares had traded hands. Daily average volume is ~846K. For MyMD ( MYMD ), the figure was ~1.6M shares (daily average ~65.7K).
• Vaxart ( VXRT ) is also developing an oral vaccine pill .

For further details see: